Le Plessis Grammoire, France

Alphonse Calenda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Isocell Pharma S.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alphonse Calenda. Retrieved from https://idiyas.com/inventor/alphonse-calenda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alphonse Calenda: Innovator in Pharmaceutical Compositions

Introduction

Alphonse Calenda is a notable inventor based in Le Plessis Grammoire, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that incorporate superoxide dismutases and prolamine-based peptide fragments.

Latest Patents

Calenda holds a patent for "Pharmaceutical compositions comprising SODs and prolamine based peptide fragments." This invention relates to pharmaceutical compositions designed for administration that include at least one superoxide dismutase and at least one prolamine-based peptide fragment. The patent also covers specific superoxide dismutases and prolamine-based peptide fragments, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Alphonse Calenda has worked with various companies, including Isocell Pharma S.A. and Isocell S.A. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical technology.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Alphonse Calenda's work in pharmaceutical compositions highlights his innovative spirit and dedication to improving healthcare solutions. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…